Semaglutide Vision Changes: Temporary Blurry Vision and Eye Risks

Dr. Daniel McGee

Medically Reviewed

Dr. Daniel McGee, D.O.

Board-certified Family Medicine Physician

Written by Rachel Sacks

Published: July 31, 2026 10 Min Read
Woman seated at a table looking at a laptop with one hand resting on her forehead.

Photo Credit: Miljan Živković / iStock

Key Takeaways

  • Blurry vision may occur when semaglutide causes rapid blood sugar changes, dehydration, or interacts with a pre-existing eye condition.
  • Vision often improves as blood sugar stabilizes, but persistent changes may signal diabetic retinopathy or another eye problem.
  • People with diabetes, existing retinopathy, high blood pressure, high cholesterol, or sleep apnea may need closer eye monitoring while taking semaglutide.
  • Sudden painless vision loss in one eye, new floaters, flashes of light, warped vision, or peripheral vision loss require prompt medical attention.
  • If you have diabetes, especially a history of retinopathy, discuss an eye exam and follow-up monitoring before starting semaglutide.

The diabetes drug, semaglutide, has been making headlines ever since the medication received FDA approval to help with blood sugar control and weight management.

This medication benefits people with type 2 diabetes and obesity. For patients with diabetes, this is especially valuable for eye health since diabetes damages the eyes over time and potentially leads to vision loss or blindness.

However, the treatment is not without adverse effects. Some studies also show it can cause vision changes, including blurred vision, and worsening of diabetic retinopathy and other eye health complications.

Read on to learn more about the connection between semaglutide and vision, including why semaglutide blurry vision is a possibility, what to discuss with your doctor, and more.

Why Vision Changes Come Up With Semaglutide

Semaglutide helps people lose weight and manage blood sugar levels by releasing the hormone GLP-1 (short for glucagon-like peptide-1), which makes us feel full while eating. This hormone also prompts the body to produce more insulin, thereby reducing blood sugar.

While this medication, like all medications, comes with potential side effects, some are more common than others. Common semaglutide side effects often involve gastrointestinal effects such as nausea, vomiting, diarrhea, bloating, and constipation, among others.

One less common but more serious adverse effect can involve changes in vision, such as blurry vision.

Blurry vision on semaglutide could happen for several reasons, such as rapid changes in blood sugar, preexisting conditions like diabetic retinopathy, a side effect from the medication, or others.

For example, dehydration while on semaglutide is possible due to vomiting or diarrhea. Dehydration throughout the whole body can lead to temporary dry eye syndrome, causing discomfort or intermittent blurriness.

Some research has also linked semaglutide to a potentially vision-threatening condition known as nonarteritic anterior ischemic optic neuropathy (NAION).

Called an “eye stroke”, NAION is a sudden loss of vision in one eye caused by reduced small vessel blood flow to the optic nerve, a large bundle of nerve fibers that transmit visual messages from the retina of the eye to the brain.

While usually painless, it can cause potential permanent loss of vision.

Diabetes, Blood Sugar Changes, and Blurry Vision

Another reason why vision can become blurry while taking semaglutide is due to how the medication affects blood sugar levels.

Semaglutide lowers blood sugar by stimulating insulin release from the pancreas and suppressing glucagon production only when blood sugar levels are high, preventing post-meal spikes.

The risk of hypoglycemia (low blood sugar) is low if the medication is taken on its own. But the risk increases if it’s combined with insulin or sulfonylureas, or if you skip meals, do intense exercise, or become dehydrated.

When the body’s blood sugar levels change rapidly, vision can be affected as the lens inside the eye swells or shifts shape.

Too much glucose in the blood can also damage the blood vessels and nerves that run throughout the body, including the eyes.

Typically, blood sugar stabilizes within the first few months of semaglutide use, after which vision returns to normal.


This is a conversation I'm having more often now that semaglutide use has grown. What I always tell patients is that mild, blurry vision in the first few weeks can happen, and usually reflects the blood sugar settling, not a sign that anything is wrong with the eyes themselves. But I always warn that sudden vision loss, new floaters, flashes of light, or loss of part of the visual field is a different story. Those symptoms need a same-day evaluation by a healthcare professional. If you have diabetes, especially with any history of retinopathy, I would recommend an eye exam before starting semaglutide and regular reviews to follow.

Dr. Daniel McGee, Board-certified Family Medicine Physician


Older patients are more likely to experience blurred vision, as the eye’s lens becomes less flexible with age and loses the ability to focus on close objects, a process known as presbyopia.

Vision then takes longer to stabilize when the body experiences these changes in blood sugar levels.

Those with diabetes are also more likely to experience other conditions that affect vision, such as cataracts or glaucoma.

A cataract is a clouding of the eye's natural lens. High blood sugar increases the risk of cataracts by causing changes in the lens that make it become cloudy over time.

Meanwhile, glaucoma is a group of eye diseases that damage the optic nerve from too much pressure in the eye.

If GLP-1 eye symptoms like blurry vision remain after a few months, it could indicate more permanent damage like diabetic retinopathy.

Clinician-Guided Weight Care

Clinician-Guided Weight Care

Start with a health assessment for a licensed provider to review. If appropriate, you'll receive a personalized GLP-1 treatment plan, with ongoing provider oversight and support, all in the app.

What Is Diabetic Retinopathy?

Diabetes can affect the eyes in several ways, including various diseases like diabetic retinopathy.

Diabetic retinopathy happens in one of two ways: when changes in the retina’s blood vessels cause leaking of the vessels or abnormal new blood vessels grow on the retina’s surface.

This damage to the retina — the thin, light-sensitive layer of tissue that lines the back of the eye — can cause blurred vision, floaters, and potential blindness.

Other symptoms can include trouble seeing colors, dark or empty areas in vision, or dark shapes in vision.

There are generally two stages of diabetic retinopathy. The early stage typically has no symptoms, although some may notice temporary vision changes that resolve on their own.

During the advanced or proliferative stage, blood vessels in the retina begin to bleed into the fluid that fills the eye, causing the appearance of dark, floating spots.

Sometimes, these spots clear up, but it’s important to get treatment as soon as possible, as scars can form in the back of the eye or the bleeding can worsen.

Treatments can start before vision is affected, with options such as laser therapy, medications such as VEGF inhibitors or corticosteroids, a surgical procedure known as vitrectomy, or reattachment of the retina if necessary.

Anyone with type 1, 2, or gestational diabetes (diabetes while pregnant) can develop the condition, especially as factors like high blood sugar, blood pressure, and cholesterol levels can increase risk.

Semaglutide has also been linked in some early clinical trials to a temporary worsening of diabetic retinopathy, due to the rapid drop in blood sugar that can stress the retina blood vessels in those with pre-existing eye disease. This is thought to be related to the rapid improvement in blood sugar levels, rather than a direct harmful effect of semaglutide on the eye.

However, large-scale evaluations of semaglutide don’t indicate an increased risk of long-term advanced retinopathy compared to other diabetes medications.

Semaglutide diabetic retinopathy is a possibility, although not so much of a concern in those without diabetic retinopathy. People with existing diabetic retinopathy or very high blood sugar should discuss appropriate eye monitoring with their healthcare provider when starting semaglutide, and let them know of any medications you’re using.

Who May Need Closer Eye Monitoring?

You should let your doctor know about any persistent adverse effects, including vision changes.

Some patients, though, may need to keep a particularly close eye on their vision while taking semaglutide

Those with pre-existing diabetic retinopathy face a higher risk of worsening vision or potential blindness when blood sugar changes due to damaged blood vessels in the retina.

People with a small or crowded optic disc structure who may carry a rare risk for NAION should also get their eyes checked more often if they start using semaglutide.

Similarly, anyone with high blood pressure, high cholesterol, or sleep apnea, or who experiences very fast drops in blood sugar levels after starting the medication, is also at an increased risk of vision changes or eye damage.

Eye Symptoms That Should Be Checked Promptly

While blurry vision is possible in the first few months of starting semaglutide due to rapid drops in blood sugar levels, these typically go away as the body adjusts.

However, other symptoms should be checked by a doctor immediately.

For example, sudden vision loss or a painless, rapid drop or dimming of vision in one eye could be a sign of a rare optic nerve issue, such as NAION.

Loss of upper, lower, or peripheral vision, sudden bursts of light or new floating spots in your vision, or warped or wavy vision are also potential urgent warning signs of a larger issue.

Questions to Ask Your Clinician or Eye Doctor

If you’re starting semaglutide, in addition to your routine doctor’s visits, be sure to visit your ophthalmologist to get your eyes checked.

Especially if you have pre-existing eye conditions or experience any unusual vision changes, regular eye exams and discussing symptoms or side effects with your doctor can help determine the best course of action for you and your health.

Some questions you may want to ask your clinician or eye doctor:

  • Do I have type 2 diabetes?
  • Have I ever been diagnosed with diabetic retinopathy?
  • When was my last dilated eye exam?
  • Have I noticed new blurry vision, floaters, dark spots, eye pain, or sudden vision loss?
  • How quickly is my blood sugar changing?
  • Should my eye doctor and prescribing clinician coordinate monitoring?
  • Is my blood sugar considered too high or "uncontrolled" before I start the semaglutide?
  • If my blood sugar is high or "uncontrolled", how will we make sure my blood sugar does not drop too quickly?

Contact a healthcare provider or eye-care professional promptly for new or worsening vision changes, sudden vision loss, eye pain, new floaters, dark areas in vision, or vision symptoms with low blood sugar symptoms.

If you have diabetes, especially with a history of retinopathy, an eye exam before starting semaglutide followed by regular reviews is highly recommended.

Bottom Line

Blurry vision is a less common but more serious side effect of semaglutide, which can result from rapid blood sugar changes, preexisting eye conditions, or the medication itself.

For most people, this resolves once blood sugar stabilizes, typically within the first few months of treatment. Vision changes that remain after that window can point to more permanent issues, such as diabetic retinopathy, particularly in those with pre-existing eye disease or diabetes.

Sudden or severe symptoms, like painless vision loss in one eye, new floaters, or loss of peripheral vision, call for prompt medical attention.

If you have diabetes, especially with a history of retinopathy, an eye exam before starting semaglutide and regular follow-up visits are recommended.

Frequently Asked Questions

Yes, semaglutide can cause temporary blurry vision due to rapid changes in blood sugar levels, although this typically goes away within the first few months.


Clinical trials of semaglutide showed an increased risk of worsening retinal disease, particularly in patients with a prior history of diabetic retinopathy.


Yes, especially if you have type 1,2 or gestational diabetes or have a pre-existing eye condition.


Some can be, while others, like blurry vision, may be a reaction to blood sugar levels dropping quickly.


Warped vision, sudden bursts of light, loss of upper, lower, or peripheral vision, or sudden, painless loss of vision in one eye.


  1. National Eye Institute. Diabetic retinopathy [Internet]. Bethesda (MD): National Eye Institute; 2025 Sep 11 [cited 2026 Jul 31]. Available from: https://www.nei.nih.gov/eye-health-information/eye-conditions-and-diseases/diabetic-retinopathy
  2. Taylor K, Tripathi AK. Adult Dehydration. [Updated 2025 Mar 5]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK555956/
  3. Novo Nordisk Pharmaceutical Industries, LP. Wegovy—semaglutide injection, solution; Wegovy—semaglutide tablet [Internet]. Bethesda (MD): National Library of Medicine (US); 2026 Jun 18 [cited 2026 Jul 31]. Available from: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b
  4. Zhao Z, Tang Y, Hu Y, Zhu H, Chen X, Zhao B. Hypoglycemia following the use of glucagon-like peptide-1 receptor agonists: a real-world analysis of post-marketing surveillance data. Ann Transl Med. 2021 Sep;9(18):1482. doi: 10.21037/atm-21-4162. PMID: 34734034; PMCID: PMC8506728: https://pmc.ncbi.nlm.nih.gov/articles/PMC8506728/
  5. American Society of Health-System Pharmacists. Semaglutide injection [Internet]. Bethesda (MD): National Library of Medicine (US); 2026 May 15 [cited 2026 Jul 31]. Available from: https://medlineplus.gov/druginfo/meds/a618008.html
  6. Centers for Disease Control and Prevention. Vision loss and diabetes [Internet]. Atlanta (GA): Centers for Disease Control and Prevention; 2024 May 15 [cited 2026 Jul 31]. Available from: https://www.cdc.gov/diabetes/diabetes-complications/diabetes-and-vision-loss.html
  7. Cleveland Clinic. Optic nerve [Internet]. Cleveland (OH): Cleveland Clinic; 2024 Apr 11 [cited 2026 Jul 31]. Available from: https://my.clevelandclinic.org/health/body/22261-optic-nerve
  8. Volpe S, Lisco G, Fanelli M, Racaniello D, Colaianni V, Lavarra V, et al. Oral semaglutide improves body composition and preserves lean mass in patients with type 2 diabetes: a 26-week prospective real-life study. Front Endocrinol (Lausanne). 2023 Sep 13;14:1240263. doi: 10.3389/fendo.2023.1240263. PMID: 37780624; PMCID: PMC10534984: https://pmc.ncbi.nlm.nih.gov/articles/PMC10534984/
  9. The DCCT Research Group. Diabetes Control and Complications Trial (DCCT): results of feasibility study. Diabetes Care [Internet]. 1987 Jan-Feb [cited 2026 Jul 31];10(1):1-19. Available from: https://diabetesjournals.org/care/article-abstract/10/1/1/768/Diabetes-Control-and-Complications-Trial-DCCT
  10. Massy M, Marti S, Hammer H, Hoepner R. Increased vision impairment reports linked to semaglutide: analysis of FDA adverse event data. BMC Med. 2025 Apr 7;23(1):203. doi: 10.1186/s12916-025-04031-z. PMID: 40189538; PMCID: PMC11974072: https://pmc.ncbi.nlm.nih.gov/articles/PMC11974072/
  11. Kaur K, Margolin E. Nonarteritic Anterior Ischemic Optic Neuropathy. [Updated 2025 Sep 14]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK559045/
  12. Johns Hopkins Medicine. Diabetes and your eyes: what you need to know [Internet]. Baltimore (MD): Johns Hopkins Medicine; 2026 Mar 26 [cited 2026 Jul 31]. Available from: https://www.hopkinsmedicine.org/health/expert-qa/diabetes-and-your-eyes-what-you-need-to-know
  13. Cleveland Clinic. Presbyopia [Internet]. Cleveland (OH): Cleveland Clinic; 2023 Jul 6 [cited 2026 Jul 31]. Available from: https://my.clevelandclinic.org/health/diseases/8577-presbyopia
  14. Cai CX, Nishimura A, Baxter S, Goetz K, Hribar M, Toy B, et al. Semaglutide and diabetic retinopathy: an OHDSI network study. BMJ Open Diabetes Res Care. 2025 Nov 4;13(6):e005424. doi: 10.1136/bmjdrc-2025-005424. PMID: 41192935; PMCID: PMC12587949: https://pmc.ncbi.nlm.nih.gov/articles/PMC12587949/
Clinician-Guided Weight Care

Clinician-Guided Weight Care

Start with a health assessment for a licensed provider to review. If appropriate, you'll receive a personalized GLP-1 treatment plan, with ongoing provider oversight and support, all in the app.

Rachel Sacks

By Rachel Sacks

Contributing Author

Rachel Sacks is a New York-based contributing writer with more than a decade of experience covering a range of topics, including weight loss, mental health, sexual wellness, skincare, and more. Her work has been featured in The New York Post, Healthline, Hims & Hers, Business Insider, and other notable publications. She graduated from Miami University in Oxford, Ohio, with dual degrees in Journalism and Art History.